Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications

Journal of the American College of Cardiology

Volumn 66, Issue 8, 2015, Pages 943-959

  Dzeshka, Mikhail S ^a,b   Lip, Gregory Y H ^a,c   Snezhitskiy, Viktor ^b   Shantsila, Eduard ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

cardiac; extracellular matrix; heart failure; myocytes; myofibroblasts

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MATRIX METALLOPROTEINASE; MICRORNA; MINERALOCORTICOID ANTAGONIST; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

AGING; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MAGNETIC RESONANCE; CELL COMMUNICATION; EXTRACELLULAR MATRIX; HEART FIBROBLAST; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE; HEREDITY; HUMAN; INFLAMMATION; META ANALYSIS (TOPIC); MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; FIBROBLAST; FIBROSIS; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; ATRIAL FIBRILLATION; FIBROBLASTS; FIBROSIS; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; PROGNOSIS;

EID: 84939498375     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.06.1313     Document Type: Review

References (148)

1. B. Burstein, and S. Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J Am Coll Cardiol 51 2008 802 809
2. D. Corradi Atrial fibrillation from the pathologist's perspective Cardiovasc Pathol 23 2014 71 84
3. D.D. McManus, A.Y. Shaikh, F. Abhishek, and et al. Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention Crit Pathw Cardiol 10 2011 46 51
4. T. Oka, and I. Komuro Molecular and cellular mechanisms of organ fibrosis [in Japanese] Nihon Rinsho 70 2012 1510 1516
5. G. Tarone, J.L. Balligand, J. Bauersachs, and et al. Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology Eur J Heart Fail 16 2014 494 508
6. C.A. Souders, S.L. Bowers, and T.A. Baudino Cardiac fibroblast: the renaissance cell Circ Res 105 2009 1164 1176
7. E.M. Zeisberg, and R. Kalluri Origins of cardiac fibroblasts Circ Res 107 2010 1304 1312
8. J.D. Lajiness, and S.J. Conway The dynamic role of cardiac fibroblasts in development and disease J Cardiovasc Transl Res 5 2012 739 748
9. P. Snider, K.N. Standley, J. Wang, and et al. Origin of cardiac fibroblasts and the role of periostin Circ Res 105 2009 934 947
10. G. Krenning, E.M. Zeisberg, and R. Kalluri The origin of fibroblasts and mechanism of cardiac fibrosis J Cell Physiol 225 2010 631 637
11. J. Andrade, P. Khairy, D. Dobrev, and et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms Circ Res 114 2014 1453 1468
12. K.S. McDowell, F. Vadakkumpadan, R. Blake, and et al. Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation Biophys J 104 2013 2764 2773
13. J. Baum, and H.S. Duffy Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol 57 2011 376 379
14. R. Khan, and R. Sheppard Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia Immunology 118 2006 10 24
15. A. Leask Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation Circ Res 106 2010 1675 1680
16. R.M. Greene, P. Nugent, P. Mukhopadhyay, D.R. Warner, and M.M. Pisano Intracellular dynamics of Smad-mediated TGFbeta signaling J Cell Physiol 197 2003 261 271
17. G.R. Grotendorst Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts Cytokine Growth Factor Rev 8 1997 171 179
18. S.J. Conway, and J.D. Molkentin Periostin as a heterofunctional regulator of cardiac development and disease Curr Genomics 9 2008 548 555
19. P. Lijnen, and V. Petrov Transforming growth factor-beta1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts Methods Find Exp Clin Pharmacol 24 2002 333 344
20. D. Zhang, V. Gaussin, G.E. Taffet, and et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice Nat Med 6 2000 556 563
21. J. Heger, B. Warga, B. Meyering, and et al. TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release J Cell Physiol 226 2011 2683 2690
22. J. Rodríguez-Vita, E. Sánchez-López, V. Esteban, and et al. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism Circulation 111 2005 2509 2517
23. P.K. Mehta, and K.K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol 292 2007 C82 C97
24. S. Sciarretta, F. Paneni, F. Palano, and et al. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction Clin Sci (London) 116 2009 467 477
25. R. Kakkar, and R.T. Lee Intramyocardial fibroblast myocyte communication Circ Res 106 2010 47 57
26. F.G. Spinale, M.L. Coker, C.V. Thomas, and et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function Circ Res 82 1998 482 495
27. H.E. Kim, S.S. Dalal, E. Young, and et al. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction J Clin Invest 106 2000 857 866
28. P. Spallarossa, P. Altieri, S. Garibaldi, and et al. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: the role of MAP kinases and NAD(P)H oxidase Circ Res 69 2006 736 745
29. Y.Y. Li, C.F. McTiernan, and A.M. Feldman Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling Cardiovasc Res 46 2000 214 224
30. J.M. Siddesha, A.J. Valente, S.S. Sakamuri, and et al. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK J Mol Cell Cardiol 65 2013 9 18
31. E. Orenes-Piñero, S. Montoro-Garcia, J.V. Patel, and et al. Role of microRNAs in cardiac remodelling: new insights and future perspectives Int J Cardiol 167 2013 1651 1659
32. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
33. R.F. Duisters, A.J. Tijsen, B. Schroen, and et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling Circ Res 104 2009 170 178 6p following 178
34. N. Liu, S. Bezprozvannaya, A.H. Williams, and et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes Dev 22 2008 3242 3254
35. S.J. Matkovich, W. Wang, Y. Tu, and et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts Circ Res 106 2010 166 175
36. T. Thum, C. Gross, J. Fiedler, and et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
37. S. Roy, S. Khanna, S.R. Hussain, and et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue Circ Res 82 2009 21 29
38. 4 J Mol Cell Cardiol 47 2009 5 14
39. E. van Rooij, L.B. Sutherland, J.E. Thatcher, and et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci U S A 105 2008 13027 13032
40. Y.F. Hu, Y.J. Chen, Y.J. Lin, and et al. Inflammation and the pathogenesis of atrial fibrillation Nat Rev Cardiol 12 2015 230 243
41. J. Jalife Mechanisms of persistent atrial fibrillation Curr Opin Cardiol 29 2014 20 27
42. T. Li, Z.L. Sun, and Q.Y. Xie Meta-analysis identifies serum C-reactive protein as an indicator of atrial fibrillation risk after coronary artery bypass graft Am J Ther 2015 Apr 21 [E-pub ahead of print]
43. Z. Jiang, L. Dai, Z. Song, and et al. Association between C-reactive protein and atrial fibrillation recurrence after catheter ablation: a meta-analysis Clin Cardiol 36 2013 548 554
44. T.G. Neilan, O.R. Coelho-Filho, R.V. Shah, and et al. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions J Am Coll Cardiol Img 6 2013 672 683
45. Q. Li, X. Liu, and J. Wei Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent Biochem Biophys Res Comm 452 2014 497 502
46. J. Wu, S. Xia, B. Kalionis, and et al. The role of oxidative stress and inflammation in cardiovascular aging BioMed Res Int 2014 2014 615312
47. R.A. Boon, K. Iekushi, S. Lechner, and et al. MicroRNA-34a regulates cardiac ageing and function Nature 495 2013 107 110
48. J.E. Cartledge, C. Kane, P. Dias, and et al. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators Cardiovasc Res 105 2015 260 270
49. N. Takeda, and I. Manabe Cellular Interplay between cardiomyocytes and nonmyocytes in cardiac remodeling Int J Inflam 2011 2011 535241
50. S. Nattel, and M. Harada Atrial remodeling and atrial fibrillation: recent advances and translational perspectives J Am Coll Cardiol 63 2014 2335 2345
51. P. Sanders, J.B. Morton, N.C. Davidson, and et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans Circulation 108 2003 1461 1468
52. C.A. Morillo, G.J. Klein, D.L. Jones, and et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation Circulation 91 1995 1588 1595
53. X. He, X. Gao, L. Peng, and et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7 Circ Res 108 2011 164 175
54. H. Li, S. Li, B. Yu, and et al. Expression of miR-133 and miR-30 in chronic atrial fibrillation in canines Mol Med Rep 5 2012 1457 1460
55. A.M. De Jong, I.C. Van Gelder, I. Vreeswijk-Baudoin, and et al. Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload PloS One 8 2013 e72651
56. T.H. Everett IV, H. Li, J.M. Mangrum, and et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation Circulation 102 2000 1454 1460
57. D. Li, S. Fareh, T.K. Leung, and et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort Circulation 100 1999 87 95
58. S. Cardin, E. Libby, P. Pelletier, and et al. Contrasting gene expression profiles in two canine models of atrial fibrillation Circ Res 100 2007 425 433
59. D. Rahmutula, G.M. Marcus, E.E. Wilson, and et al. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1 Cardiovasc Res 99 2013 769 779
60. D. Filgueiras-Rama, N.F. Price, R.P. Martins, and et al. Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium Circ Arrhythm Electrophysiol 5 2012 1160 1167
61. R.P. Martins, K. Kaur, E. Hwang, and et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation Circulation 129 2014 1472 1482
62. B.A. Schoonderwoerd, M.D. Smit, L. Pen, and et al. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation' Europace 10 2008 668 673
63. I. Grundvold, J. Bodegard, P.M. Nilsson, and et al. Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study Cardiovasc Diabetol 14 2015 5
64. R.K. Pathak, R. Mahajan, D.H. Lau, and et al. The implications of obesity for cardiac arrhythmia mechanisms and management Can J Cardiol 31 2015 203 210
65. H.S. Abed, C.S. Samuel, D.H. Lau, and et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation Heart Rhythm 10 2013 90 100
66. R.K. Chilukoti, A. Giese, W. Malenke, and et al. Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria Int J Cardiol 187 2015 604 613
67. M.V. Matassini, M. Brambatti, F. Guerra, and et al. Sleep-disordered breathing and atrial fibrillation: review of the evidence Cardiol Rev 23 2015 79 86
68. F. Gramley, J. Lorenzen, B. Jedamzik, and et al. Atrial fibrillation is associated with cardiac hypoxia Cardiovasc Pathol 19 2010 102 111
69. P. Ramos, C. Rubies, M. Torres, and et al. Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells Respir Res 15 2014 54
70. Y.K. Iwasaki, T. Kato, F. Xiong, and et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model J Am Coll Cardiol 64 2014 2013 2023
71. T.G. Neilan, H. Farhad, J.A. Dodson, and et al. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation J Am Heart Assoc 2 2013 e000421
72. C. Mahnkopf, T.J. Badger, N.S. Burgon, and et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation Heart Rhythm 7 2010 1475 1481
73. M.S. Olesen, M.W. Nielsen, S. Haunsø, and et al. Atrial fibrillation: the role of common and rare genetic variants Eur J Hum Genet 22 2014 297 306
74. J.M. Anumonwo, and J. Kalifa Risk factors and genetics of atrial fibrillation Cardiol Clin 32 2014 485 494
75. A. Chinchilla, H. Daimi, E. Lozano-Velasco, and et al. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis Circ Cardiovasc Genet 4 2011 269 279
76. L.H. Ling, P.M. Kistler, A.H. Ellims, and et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction J Am Coll Cardiol 60 2012 2402 2408
77. N. Sasaki, Y. Okumura, I. Watanabe, and et al. Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation Int J Cardiol 176 2014 1064 1066
78. E. Shantsila, A. Shantsila, A.D. Blann, and et al. Left ventricular fibrosis in atrial fibrillation Am J Cardiol 111 2013 996 1001
79. S.I. Chrysostomakis, I.K. Karalis, E.N. Simantirakis, and et al. Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model Cardiovasc Drugs Ther 21 2007 357 365
80. B. Avitall, J. Bi, A. Mykytsey, and A. Chicos Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control Heart Rhythm 5 2008 839 845
81. B. Burstein, E. Libby, A. Calderone, and et al. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences Circulation 117 2008 1630 1641
82. B. Ambale-Venkatesh, J.A. Lima, and M.R.I. Cardiac a central prognostic tool in myocardial fibrosis Nat Rev Cardiol 12 2015 18 29
83. L.M. Iles, A.H. Ellims, H. Llewellyn, and et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis Eur Heart J Cardiovasc Imaging 16 2015 14 22
84. H. Zhu, W. Zhang, M. Zhong, and et al. Myocardial ultrasonic integrated backscatter analysis in patients with chronic atrial fibrillation Int J Cardiovasc Imaging 26 2010 861 865
85. L. Longobardo, M.C. Todaro, C. Zito, and et al. Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review Eur Heart J Cardiovasc Imaging 15 2014 1 5
86. M. Habibi, J.A. Lima, I.M. Khurram, and et al. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study Circ Cardiovasc Imaging 8 2015 e002769
87. J.J. Bax, N.A. Marsan, and V. Delgado Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation Heart 101 2015 94 100
88. D.C. Peters, J.V. Wylie, T.H. Hauser, and et al. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study J Am Coll Cardiol Img 2 2009 308 316
89. M. Daccarett, T.J. Badger, N. Akoum, and et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation J Am Coll Cardiol 57 2011 831 838
90. N. Akoum, G. Fernandez, B. Wilson, and et al. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation J Cardiovasc Electrophysiol 24 2013 1104 1109
91. K.M. Gurses, M.U. Yalcin, D. Kocyigit, and et al. Effects of persistent atrial fibrillation on serum galectin-3 levels Am J Cardiol 115 2015 647 651
92. A. Frustaci, M. Caldarulo, A. Buffon, and et al. Cardiac biopsy in patients with "primary" atrial fibrillation: histologic evidence of occult myocardial diseases Chest 100 1991 303 306
93. A. Bayes-Genis, M. de Antonio, J. Vila, and et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3 J Am Coll Cardiol 63 2014 158 166
94. N. Lopez-Andrès, P. Rossignol, W. Iraqi, and et al. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial Eur J Heart Fail 14 2012 74 81
95. R. Querejeta, B. López, A. González, and et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis Circulation 110 2004 1263 1268
96. W. Kosmala, M. Przewlocka-Kosmala, H. Szczepanik-Osadnik, and et al. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade Heart 99 2013 320 326
97. D.M. Kaye, O. Khammy, J. Mariani, and et al. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure Eur J Heart Fail 15 2013 292 298
98. H. Krum, M. Elsik, H.G. Schneider, and et al. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy Circ Heart Fail 4 2011 561 568
99. T.G. Neilan, R.V. Shah, S.A. Abbasi, and et al. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation J Am Coll Cardiol 62 2013 2205 2214
100. T.G. Neilan, F.P. Mongeon, R.V. Shah, and et al. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation J Am Coll Cardiol Img 7 2014 1 11
101. 1 mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation Circ Arrhythm Electrophysiol 7 2014 834 840
102. L.H. Ling, A.J. Taylor, A.H. Ellims, and et al. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation Heart Rhythm 10 2013 1334 1339
103. I. Savelieva, N. Kakouros, A. Kourliouros, and et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention Europace 13 2011 308 328
104. A.J. Camm, P. Kirchhof, G.Y. Lip, et al. for the European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
105. O. Adam, D. Lavall, K. Theobald, and et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation J Am Coll Cardiol 55 2010 469 480
106. O. Adam, B. Löhfelm, T. Thum, and et al. Role of miR-21 in the pathogenesis of atrial fibrosis Basic Res Cardiol 107 2012 278
107. H. Cao, Q. Li, M. Li, and et al. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation Int J Cardiol 166 2013 702 708
108. K. Dawson, R. Wakili, B. Ordög, and et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation Circulation 127 2013 1466 1475 1475e1-28
109. F. Gramley, J. Lorenzen, J. Plisiene, and et al. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation J Cardiovasc Electrophysiol 18 2007 1076 1082
110. F. Gramley, J. Lorenzen, E. Koellensperger, and et al. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway Int J Cardiol 143 2010 405 413
111. E.M. Kallergis, E.G. Manios, E.M. Kanoupakis, and et al. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover J Am Coll Cardiol 52 2008 211 215
112. W.C. Ko, C.Y. Hong, S.M. Hou, and et al. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes Circ J 75 2011 1592 1600
113. Y. Li, Z. Jian, Z.Y. Yang, and et al. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation Cardiology 124 2013 233 240
114. F. Mayyas, M. Niebauer, A. Zurick, and et al. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease Circ Arrhythm Electrophysiol 3 2010 369 379
115. H. Nishi, T. Sakaguchi, S. Miyagawa, and et al. Impact of microRNA expression in human atrial tissue in patients with atrial fibrillation undergoing cardiac surgery PloS One 8 2013 e73397
116. Y. Okumura, I. Watanabe, T. Nakai, and et al. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence J Cardiovasc Electrophysiol 22 2011 987 993
117. V. Polyakova, S. Miyagawa, Z. Szalay, and et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation J Cell Mol Med 12 2008 189 208
118. Y.C. Qu, Y.M. Du, S.L. Wu, and et al. Activated nuclear factor-κB and increased tumor necrosis factor-α in atrial tissue of atrial fibrillation Scand Cardiovasc J 43 2009 292 297
119. B. Richter, M. Gwechenberger, A. Socas, and et al. Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome Int J Cardiol 152 2011 231 236
120. V. Rudolph, R.P. Andrié, T.K. Rudolph, and et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation Nat Med 16 2010 470 474
121. M.F. Swartz, G.W. Fink, M.F. Sarwar, and et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation J Am Coll Cardiol 60 2012 1799 1806
122. J. Wang, Y. Wang, J. Han, and et al. Integrated analysis of microRNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal atrial fibrillation: role of miR-146b-5p in atrial fibrosis Heart Rhythm 12 2015 1018 1026
123. M. Wilhelm, W. Kirste, S. Kuly, and et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation Heart Lung Circ 15 2006 30 37
124. C.H. Wu, Y.F. Hu, C.Y. Chou, and et al. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation Heart Rhythm 10 2013 10 15
125. L. Xi, H. Cao, J. Zhu, and et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery Cardiology 124 2013 18 24
126. X. Xie, Y. Liu, S. Gao, and et al. Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation Circ J 78 2014 338 344
127. G.J. Xu, T.Y. Gan, B.P. Tang, and et al. Differential expression of collagen and matrix metalloproteinases between left and right atria in patients with chronic atrial fibrillation [in Chinese] Sheng Li Xue Bao 61 2009 211 216
128. S. Cardin, E. Guasch, X. Luo, and et al. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure Circ Arrhythm Electrophysiol 5 2012 1027 1035
129. S. Saba, A.M. Janczewski, L.C. Baker, and et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-α Am J Physiol Heart Circ Physiol 289 2005 H1456 H1467
130. S. Verheule, T. Sato, T.I.V. Everett, and et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-β1 Circ Res 94 2004 1458 1465
131. N. Akoum, M. Daccarett, C. McGann, and et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach J Cardiovasc Electrophysiol 22 2011 16 22
132. U. Canpolat, A. Oto, T. Hazirolan, and et al. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy J Cardiovasc Electrophysiol 26 2015 251 259
133. D.W. den Uijl, V. Delgado, M. Bertini, and et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation Heart 97 2011 1847 1851
134. J.E. Ho, X. Yin, D. Levy, and et al. Galectin 3 and incident atrial fibrillation in the community Am Heart J 167 2014 729 734.e1
135. J. Kornej, J. Schmidl, L. Ueberham, and et al. Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation PloS One 10 2015 e0123574
136. T. Kubota, M. Kawasaki, N. Takasugi, and et al. Left atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: results from a prospective study of three-years follow-up Cardiovasc Ultrasound 10 2012 28
137. S.S. Kuppahally, N. Akoum, T.J. Badger, and et al. Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging Am Heart J 160 2010 877 884
138. L.H. Ling, A.J. McLellan, A.J. Taylor, and et al. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation Heart Rhythm 11 2014 1551 1559
139. L.C. Malcolme-Lawes, C. Juli, R. Karim, and et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study Heart Rhythm 10 2013 1184 1191
140. N.F. Marrouche, D. Wilber, G. Hindricks, and et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study JAMA 311 2014 498 506
141. C. McGann, N. Akoum, A. Patel, and et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI Circ Arrhythm Electrophysiol 7 2014 23 30
142. R.S. Oakes, T.J. Badger, E.G. Kholmovski, and et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation Circulation 119 2009 1758 1767
143. A. Olasinska-Wisniewska, T. Mularek-Kubzdela, S. Grajek, and et al. Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations Ann Thorac Surg 93 2012 1449 1455
144. S.J. Park, Y.K. On, J.S. Kim, and et al. Transforming growth factor β1-mediated atrial fibrotic activity and the recovery of atrial mechanical contraction after surgical maze procedure Int J Cardiol 164 2013 232 237
145. M. Rienstra, X. Yin, M.G. Larson, and et al. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation Am Heart J 167 2014 109 115.e2
146. M.A. Rosenberg, M. Maziarz, A.Y. Tan, and et al. Circulating fibrosis biomarkers and risk of atrial fibrillation: the Cardiovascular Health Study (CHS) Am Heart J 167 2014 723 728.e2
147. J. Seitz, J. Horvilleur, J. Lacotte, and et al. Correlation between AF substrate ablation difficulty and left atrial fibrosis quantified by delayed-enhancement cardiac magnetic resonance Pacing Clin Electrophysiol 34 2011 1267 1277
148. G.D. Wang, L.H. Shen, L. Wang, and et al. Relationship between integrated backscatter and atrial fibrosis in patients with and without atrial fibrillation who are undergoing coronary bypass surgery Clin Cardiol 32 2009 E56 E61